Much of the research surrounding childhood asthma has sought new approaches to managing the disease. However, little was done to address other conditions that often appear along with asthma including depression and Attention Deficit Hyperactivity Disorder (ADHD), which can negatively affect a child?s ability to cope.
Asthma symptoms vary greatly among individuals and vary at times with each individual. In this comprehensive study in the April issue of Mayo Clinic Proceedings, researchers address the prevalence and process of step-down therapy as symptoms subside.
Exposure to mould at home may increase the risk of breathing problems in people who suffer from asthma, results of a UK study suggest.
Theravance, Inc. (NASDAQ: THRX) announced the results of two studies in an ongoing Phase 2b clinical program to assess the efficacy and safety of the investigational bronchodilators GSK642444 (‘444) and GSK159797 (‘797), the lead long-acting Beta2 agonist (LABA) compounds in the Beyond Advair collaboration with GlaxoSmithKline (GSK).
For overweight and obese individuals, the incidence of asthma increases by 50 percent, as compared to those of normal weight, according to a meta-analysis of seven studies on severe asthma involving 333,102 patients.
The city of London has launched an innovative service, funded by ESA, which delivers air pollution alerts and health advice via SMS text messages to those who suffer from asthma and other conditions vulnerable to poor air quality.
A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.
A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according to a review in today’s (March 29) New England Journal of Medicine.
A nationwide, multi-center clinical trial of the American Lung Association?s Asthma Clinical Research Centers (ACRC) has found that neither low-dose theophylline nor montelukast improve asthma control in people who were using just a short acting inhaled bronchodilator, but that low-dose theophylline is beneficial in those patients who had not been prescribed inhaled corticosteroids.
Children in the United States suffer from asthma more than any other chronic illness, and new research finds African-American children with the condition have a greater risk than others of experiencing severe symptoms that escalate into an emergency.